Who
Michael E. McFadden
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Alpha Cognition; CCO/Urovant Sciences, Inc., Urovant Sciences.
In numbers
- Trades disclosed
- 10
- Buys
- 1
- Sells
- 0
- Bought
- $15K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 15 Oct 2018
- Last trade
- 9 Jan 2026
- Last filed
- 13 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 13 Jan 2026 | ACOG Alpha CognitionBiotechnology | SEC FORM 4 Code A | —190,549 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | ACOG Alpha Cognitionoption or derivative · Biotechnology | SEC FORM 4 Code A | —177,576 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | ACOG Alpha Cognitionoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,220 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | ACOG Alpha Cognitionoption or derivative · Biotechnology | SEC FORM 4 Code A | —177,576 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | ACOG Alpha Cognitionoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,220 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | ACOG Alpha CognitionBiotechnology | SEC FORM 4 Code A | —190,549 at $0.00 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ACOG Alpha Cognitionoption or derivative · Biotechnology | SEC FORM 4 Code A | —496,947 at $0.00 | filing |
| 13 Nov 2024filed 15 Nov 2024 | ACOG Alpha CognitionBiotechnology | SEC FORM 4 Bought | $15K2,608 at $5.75 | filing |
| 6 Jan 2019filed 8 Jan 2019 | Urovant Sciencesoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Oct 2018filed 17 Oct 2018 | Urovant Sciencesoption or derivative | SEC FORM 4 Code A | —4,750 at $0.00 | filing |
News
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®ACOG · standard-freeholder.com · 13 Oct 2026Alpha Cognition Inc. (NASDAQ:ACOG) Stock Now Rated "Buy" by Sell-Side BrokeragesACOG · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Michael E. McFadden; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.